Biostar Pharmaceuticals Operating Income

Biostar Pharmaceuticals (BSPM) currently reports a operating income of $3.3M as of September 2017. That compares with $-30M in the prior-year period — up 111.0% year over year. Use the charts on this page to explore Biostar Pharmaceuticals's operating income history and peer comparisons.

Biostar Pharmaceuticals's operating income increased from $-30M to $3.3M — a 111.0% year-over-year increase (period ending September 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biostar Pharmaceuticals reported $3.3M in operating income as of September 2017. That compares with $-30M in the prior-year period — up 111.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $3.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biostar Pharmaceuticals, and consider following BSPM for alerts when major investors trade the stock.